Charles River Laboratories International, Inc. (CRL) closed at $302.03 on October 15, 2026, marking a 1.00% gain over the prior 24-hour period. The move added to a modest weekly uptick of 0.61%, pointing to steady near-term buying interest in the stock.
Over the past 30 days, CRL has advanced 10.64%, reflecting a notably stronger trend on the longer time horizon. The company's market capitalization stood at $14.27 billion as of the same date.
The 30-day performance stands out as the most significant driver of recent momentum, with the stock building gains across multiple timeframes. The 24-hour and 7-day figures suggest the pace of that advance has moderated somewhat heading into mid-October.
CRL operates as a provider of research models, preclinical, and clinical laboratory services to the pharmaceutical and biotechnology industries. The stock's price and market capitalization data reflect trading conditions as of October 15, 2026.
